Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Vitamin D compounds for people with chronic kidney disease requiring dialysis
Cochrane Reviews, 10/19/09
Palmer SC et al. – The authors identified 60 studies of vitamin D preparations in people with CKD and requiring dialysis involving 2773 people. No studies were designed to understand the effect of vitamin D therapy on risks of death. Vitamin D agents suppress parathyroid hormone (PTH) significantly compared with no treatment, however also increase both circulating calcium and phosphorus levels. Intravenous vitamin D may lower PTH more than oral vitamin D. Few studies directly compare newer vitamin D therapies with earlier (and presently more common treatment options; calcitriol and alfacalcidol); newer treatment options therefore cannot be recommended as superior to established treatments.
Related Articles
Vitamin D compounds for people with chronic kidney disease not requiring dialysis
Cochrane Reviews, 10/23/09
Relevance Score: 98%
Is normalising haemoglobin in patients with CKD harmful and if so, why
Journal of Renal Care, 11/17/09
Relevance Score: 94%
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial
Nephrology Dialysis Transplantation, 11/17/09
Relevance Score: 94%
C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study
Hemodialysis International, 11/05/09
Relevance Score: 94%
The Impact of Dialysis Modality on Serum Heat Shock Proteins in Children and Young Adults with Chronic Kidney Disease
Kidney and Blood Pressure Research, 11/05/09
Relevance Score: 94%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Outcome of atrial fibrillation among patients with end-stage renal disease
Nephrology Dialysis Transplantation, 11/20/09
Prevalence and complications of chronic kidney disease in paediatric renal transplantation: a K/DOQI perspective
Nephrology Dialysis Transplantation, 11/20/09
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing
Nephrology Dialysis Transplantation, 11/20/09
Endothelial Dysfunction in Peritoneal Dialysis Patients With and Without Failed Renal Transplants
Transplantation Proceedings, 11/20/09
Predictors of Early Postoperative Hypocalcemia in Hemodialysis Patients With Secondary Hyperparathyroidism
Transplantation Proceedings, 11/20/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Sirolimus Therapy for Patients With Adult Polycystic Kidney Disease: A Pilot Study
Transplantation Proceedings, 11/20/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Evaluation of Tolerability and Ability to Increase Immunosuppression in Renal Transplant Patients Converted From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium
Transplantation Proceedings, 11/20/09
Article Search
Sponsor


See Latest Articles


